Literature DB >> 22734814

Neurogenic inflammation in allergen-challenged obese mice: A missing link in the obesity-asthma association?

Renata Ramalho1, Joana Almeida, Marília Beltrão, Ana Pirraco, Raquel Costa, Oksana Sokhatska, Luísa Guardão, Carmo Palmares, João Tiago Guimarães, Luís Delgado, André Moreira, Raquel Soares.   

Abstract

AIM: A number of studies have shown an association between obesity and asthma. Controversy remains on the mechanisms supporting this association. In this study we aimed to assess neurogenic inflammation in a model of diet-induced obesity and allergen-challenged mice.
METHODS: High fat diet-induced (HFD) obese Balb/c mice were sensitized and challenged with ovalbumin (OVA). Glucose, insulin, OVA-specific IgE and substance P (SP), and the main tachykinin involved in neurogenic inflammation, were quantified in sera. Cell counts were performed in bronchoalveolar lavage fluid (BALF). The extent of peribronchial infiltrates was estimated on lung tissue sections and inflammation was score based on inflammatory cell counts surrounding the bronchi.
RESULTS: Obesity per se and allergen-sensitization per se increased serum SP (P = .027, P = .004, respectively). Further increased was observed in obese-sensitized mice (P = .007). Obese-sensitized mice also showed higher insulin (P = .0016), OVA-specific IgE (P = .016), peribronchial inflammatory score (P = .045), and tendency for higher glycemia. The interaction of obesity and asthma on SP levels was confirmed (P = .005, R(2) = 0.710). SP was positively correlated with metabolic (glycemia, r = 0.539, P = .007) and allergic inflammation parameters (BALF eosinophils, r = 0.445, P = 0.033; BALF mast cells, r = 0.574, P = .004; peribronchial inflammation score, r = 0.661, P < .001; and OVA-specific IgE, r = 0.714, P < .001).
CONCLUSIONS: Our findings provide support to the neurogenic inflammation link between obesity and asthma in mice. These two conditions independently increased SP and the presence of both pathologies further increased this level. Neurogenic inflammation may be a previously unrecognized mechanism beyond the obese-asthma phenotype. Further studies are need to confirm this role of SP in human obesity-asthma association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734814     DOI: 10.3109/01902148.2012.699589

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  4 in total

1.  Leptin Deficiency Shifts Mast Cells toward Anti-Inflammatory Actions and Protects Mice from Obesity and Diabetes by Polarizing M2 Macrophages.

Authors:  Yi Zhou; Xueqing Yu; Huimei Chen; Sara Sjöberg; Joséphine Roux; Lijun Zhang; Al-Habib Ivoulsou; Farid Bensaid; Cong-Lin Liu; Jian Liu; Joan Tordjman; Karine Clement; Chih-Hao Lee; Gokhan S Hotamisligil; Peter Libby; Guo-Ping Shi
Journal:  Cell Metab       Date:  2015-10-17       Impact factor: 27.287

Review 2.  Immunological characteristics and management considerations in obese patients with asthma.

Authors:  Jennifer L Ather; Matthew E Poynter; Anne E Dixon
Journal:  Expert Rev Clin Immunol       Date:  2015-04-27       Impact factor: 4.473

Review 3.  Immunometabolism in obese asthmatics: are we there yet?

Authors:  Hashim A Periyalil; Peter G Gibson; Lisa G Wood
Journal:  Nutrients       Date:  2013-09-10       Impact factor: 5.717

4.  Taeumjowi-tang, a Traditional Korean Sasang Remedy, Improves Obesity-Atopic Dermatitis Comorbidity by Regulating Hypoxia-Inducible Factor 1 Alpha.

Authors:  Jinbong Park; Dong-Hyun Youn; JongWook Kang; Kwang Seok Ahn; Hyun Jeong Kwak; Jae-Young Um
Journal:  Front Pharmacol       Date:  2019-12-20       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.